Heparin sodium and Cefaclor drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Heparin sodium (heparin sodium) and Cefaclor (cefaclor). Common drug interactions include nausea among females and incision site pain among males.

The phase IV clinical study analyzes what interactions people have when they take Heparin sodium and Cefaclor. It is created by eHealthMe based on reports of 22 people who take the same drugs from the FDA, and is updated regularly.

What is Heparin sodium?

Heparin sodium has active ingredients of heparin sodium. It is often used in deep venous thrombosis. eHealthMe is studying from 21,065 Heparin sodium users. Check the latest studies of Heparin sodium.

What is Cefaclor?

Cefaclor has active ingredients of cefaclor. eHealthMe is studying from 2,512 Cefaclor users. Check the latest studies of Cefaclor.



On Jul, 14, 2026

22 people who take Heparin sodium and Cefaclor together, and have interactions are studied.

Heparin sodium and Cefaclor drug interactions.

What are the common drug interactions of Heparin Sodium and Cefaclor, by gender? *:

female:

  1. Nausea (feeling of having an urge to vomit)
  2. Vomiting
  3. Pyrexia (fever)
  4. Urinary tract infection
  5. Blood albumin decreased
  6. Blood creatinine increased
  7. Blood urea increased
  8. Dizziness
  9. Haemoglobin decreased
  10. Hydronephrosis (water inside the kidney)

male:

  1. Incision site pain
  2. Blood glucose increased
  3. Cardiac failure
  4. Chest discomfort
  5. Hyperlipidaemia (presence of excess lipids in the blood)
  6. Kidney transplant rejection
  7. Oedema peripheral (superficial swelling)
  8. Platelet count decreased
  9. Throat irritation
  10. Upper respiratory tract infection

What are the common drug interactions of Heparin Sodium and Cefaclor, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

  1. Device dislocation
  2. Umbilical hernia (an outward bulging (protrusion) of the abdominal lining or part of the abdominal organ(s) through the area around the belly button)
  3. Weight gain poor

10-19:

  1. Abdominal distension
  2. Abdominal pain

20-29:

  1. Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures)

30-39:

  1. Lymphocyte count decreased
  2. Haemoglobin decreased
  3. Blood albumin decreased
  4. Blood creatinine increased
  5. Blood urea increased
  6. Dizziness
  7. Hydronephrosis (water inside the kidney)
  8. Nausea (feeling of having an urge to vomit)
  9. Neutrophil count increased (excess than normal number of neutrophil a type of blood cell)
  10. Protein urine present

40-49:

  1. Cardiac failure
  2. Chest discomfort
  3. Hyperlipidaemia (presence of excess lipids in the blood)
  4. Incision site pain
  5. Kidney transplant rejection
  6. Oedema peripheral (superficial swelling)
  7. Platelet count decreased
  8. Throat irritation
  9. Upper respiratory tract infection

50-59:

  1. Catheter site infection (infection at the site of insertion)
  2. Abdominal pain
  3. Arthralgia (joint pain)
  4. Back pain
  5. Blood potassium decreased
  6. Blood pressure decreased
  7. Catheter site erythema (redness of skin at catheter site)
  8. Chest pain
  9. Circulatory collapse
  10. Constipation

60+:

  1. Respiratory failure (inadequate gas exchange by the respiratory system)
  2. Arteriosclerosis coronary artery (thickening and hardening of arteries- coronary artery)
  3. Insomnia (sleeplessness)
  4. Metastases to peritoneum (cancer spreads to peritoneum)
  5. Osteoporosis (bones weak and more likely to break)
  6. Pneumonia
  7. Postrenal failure (postrenal acute renal failure)
  8. Pyelonephritis acute (sudden inflammation of kidney caused by bacteria)
  9. Pyrexia (fever)
  10. Restlessness (not able to rest)

What are the existing conditions these people have? *

  1. High Blood Pressure: 9 people, 40.91%
  2. Wheezing (a high-pitched whistling sound made while you breath): 6 people, 27.27%
  3. B Precursor Type Acute Leukaemia (lymphoid cancer): 6 people, 27.27%
  4. Constipation: 6 people, 27.27%
  5. Pain: 6 people, 27.27%
  6. Urination - Excessive Volume: 6 people, 27.27%
  7. Sedation: 5 people, 22.73%
  8. Cardiac Disorder: 5 people, 22.73%
  9. Thrombosis (formation of a blood clot inside a blood vessel): 5 people, 22.73%
  10. Respiratory Disorder (respiratory disease): 4 people, 18.18%

* Approximation only. Some reports may have incomplete information.

Do you take Heparin sodium and Cefaclor?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Heparin sodium and Cefaclor:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Heparin sodium:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Cefaclor:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Heparin sodium and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Cefaclor and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on heparin sodium and cefaclor (the active ingredients of Heparin sodium and Cefaclor, respectively), and Heparin sodium and Cefaclor (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: